Lenovo (00992) Motorola's mobile phone Q2 revenue achieved double-digit growth, firmly ranking fourth in the overseas market.
Lenovo Motorola phones remain steady in the overseas market, ranking fourth.
The latest report from the International Data Corporation (IDC) shows that the total revenue of smartphones in overseas markets, excluding China, reached 91.3 billion US dollars, a year-on-year increase of 9.2%, significantly exceeding the previously expected growth of 1.2%. In this context, LENOVO GROUP's mobile business performed exceptionally well in overseas markets, solidifying its position as the fourth largest globally with strong double-digit revenue growth: revenue soared 14.6% year-on-year, with a market share reaching 5.4%. At the same time, Lenovo Motorola's revenue share worldwide also grew to 3.0%, ranking eighth.
It is worth noting that this high revenue growth rate leads the top 5 overseas markets (Apple's year-on-year growth is 9.7%, Samsung's year-on-year growth is 11.3%, Xiaomi's year-on-year growth is 3.7%, and Oppo's year-on-year growth is -1%), even within the top 10 global markets, this revenue growth rate is second only to Google's smartphones, highlighting its advantage in overseas emerging markets.
The Asia-Pacific emerging markets and North American markets are the two major growth engines for Lenovo this quarter:
- Revenue in Asia-Pacific emerging markets increased by 66% year-on-year, with the Indian market continuing its strong growth momentum with a year-on-year growth rate of 44%. According to the latest data from another institution, TechInsights, in the Japanese market, Lenovo Motorola and Fujitsu brand (arrows and RakuRaku) smartphones collectively shipped more than 700,000 units in the second quarter, consistently ranking in the top three in the Japanese market for three consecutive quarters (behind only Apple and Google).
- Revenue in the North American market reached 1.07 billion US dollars, an increase of 18.2% year-on-year, with a market share of 5.3%, ranking third. The US market holds a 5.6% market share, ranking third.
Market research firm CounterPoint analysis believes that this quarter, Lenovo Motorola stood out as one of the fastest-growing major brands in terms of revenue, benefiting from strong sales in the Indian market, steady expansion in the North American prepaid market, and increased competitiveness in the mid-range 5G product category.
In the context of a decline in the Chinese domestic smartphone market, Lenovo Motorola is bucking the trend: revenue increased significantly by 52% year-on-year, and shipments increased by 32% year-on-year, demonstrating strong growth momentum.
In the just-ended 2024-25 fiscal year, Motorola's revenue reached 62.6 billion yuan, an increase of 27% year-on-year, setting a new historical record since being acquired by Lenovo, and the shipment of phones increased by 75% compared to 2020. In the first quarter of 2025, Lenovo Motorola's revenue share in the global market outside China already surpassed Oppo, Transsion, and Google, rising from fifth to fourth place. In the second quarter, Lenovo continued to consolidate its fourth position. In the background of global smartphone competition entering a stock game, double-digit revenue growth confirms Lenovo's strategic strength and execution in emerging markets.
The market expects the trend of high-end smartphones in the global market to continue, and revenue growth in 2025 is expected to outperform sales growth. In addition, as the attention on generative artificial intelligence (GenAI) smartphones and foldable screen models continues to rise, Lenovo Motorola is expected to leverage its strong accumulation in the personal smart field and foldable screen phones to harvest significant growth opportunities.
Related Articles

CANBRIDGE-B (01228) plans to appoint Qingdao Baheal Medical INC. as its exclusive contract sales organization to promote several products of the group.

CANBRIDGE-B (01228) intends to issue approximately 19.76% of 749.715 million shares for subscription, raising around 98.618 million Hong Kong dollars. Trading will resume on August 13th.

CHINARES PHARMA (03320) intends to participate in the establishment of a fund.
CANBRIDGE-B (01228) plans to appoint Qingdao Baheal Medical INC. as its exclusive contract sales organization to promote several products of the group.

CANBRIDGE-B (01228) intends to issue approximately 19.76% of 749.715 million shares for subscription, raising around 98.618 million Hong Kong dollars. Trading will resume on August 13th.

CHINARES PHARMA (03320) intends to participate in the establishment of a fund.

RECOMMEND

Virtually Unprecedented! U.S. Government’s Revenue Take from China-Bound Chip Exports Sparks Outcry, Multiple Policies Suspected as Revenue-Generation Measures
12/08/2025

Policy Continuity Catalyzes Market Potential Release; New Energy Vehicle Penetration Nears 50% in July
12/08/2025

Embodied Intelligence Applications Proliferate Across Industries; 2026 Poised to Mark the Inaugural Year of Mass Production
12/08/2025